Q&A: BioNTech vaccine is only ‘mRNA 1.0’. This is just the beginning, say co-founders | Horizon: the EU Research & Innovation magazine | European Commission

The successful development of mRNA vaccines for Covid-19 is ‘transformational’ and opens the doors to new types of vaccines for other infectious diseases as well as cancer, according to Dr Özlem Türeci and Dr Uğur Şahin, the co-founders of Germany’s BioNTech.